TrialNature medicine2021

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Jordan R Barrett et al.PubMed ↗Publisher ↗

No numbers read from the abstract.